Gene Biotherapeutics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Gene Biotherapeutics, Inc. had Stockholders' Equity Attributable to Noncontrolling Interest of -$693.16 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2022-04-14
- 2020-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$693.16K.
- 2020-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$646.44K.
- 2020-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$606.16K.
- 2020-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$578.55K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2020-12-31 | -$693.16K 10-K/A · filed 2022-04-14 |
| 2020-09-30 | -$646.44K 10-Q · filed 2021-10-27 |
| 2020-06-30 | -$606.16K 10-Q · filed 2021-09-17 |
| 2020-03-31 | -$578.55K 10-Q · filed 2021-09-03 |
| 2019-12-31 | -$559.50K 10-K/A · filed 2022-04-14 |
| 2018-12-31 | -$471.96K 10-K · filed 2021-04-23 |
| 2017-12-31 | -$354.09K 10-K · filed 2021-04-23 |
| 2017-03-31 | -$226.89K 10-Q · filed 2017-07-28 |
| 2016-12-31 | -$151.73K 10-K · filed 2017-07-28 |